Infusion of ovine C5a into sheep mimics the inflammatory response of hemodialysis

Journal of Laboratory and Clinical Medicine

Volumn 127, Issue 5, 1996, Pages 456-469

  Johnson, Richard J ^a,b   Burhop, Kenneth E ^a   Van Epps, Dennis E ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b Baxter Technology Park   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; PHORBOL 13 ACETATE 12 MYRISTATE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; HUMAN; INFLAMMATION; KINETICS; LEUKOCYTE COUNT; METABOLISM; MOLECULAR GENETICS; NEUTROPENIA; NEUTROPHIL; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; RESPIRATORY BURST; SEQUENCE HOMOLOGY; SHEEP;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PRESSURE; COMPLEMENT C5A; DISEASE MODELS, ANIMAL; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; INFLAMMATION; KINETICS; LEUKOCYTE COUNT; MOLECULAR SEQUENCE DATA; NEUTROPENIA; NEUTROPHILS; RENAL DIALYSIS; RESPIRATORY BURST; SEQUENCE HOMOLOGY; SHEEP; TETRADECANOYLPHORBOL ACETATE;

EID: 0030137951     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90063-3     Document Type: Article

References (42)

1. Chenoweth DE. Complement activation by biomaterials. Trans Am Soc Artif Intern Organs 1986;32:226-32.
2. Johnson RJ. Complement activation during extracorporeal therapy: biochemistry, cell biology and clinical relevance. Nephrol Dial Transplant 1994;9:36-45.
3. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS. Pulmonary vascular leukostasis resulting from complement activation by dialyzer membranes. J Clin Invest 1977;59:879-88.
4. Cheung AK, LeWinter M, Chenoweth DE, Lew WYW, Henderson LW. Cardiopulmonary effects of cuprophane-activated plasma in pigs. Kidney Int 1986;29:799-806.
5. Matsuda T, Itoh S, Anderson J. Endothelial injury during extracorporeal circulation: neutrophil-endothelial interaction induced by complement activation. J Biomater Res 1994;28: 1387-95.
6. Ivanovich P, Chenoweth DE, Schmidt R, et al. Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int 1983;24:758-63.
7. Himmelfarb J, Lazarus JM, Hakim R. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991;17:271-6.
8. Cheung AK, Baranowski RL, Wayman AL. The role of thromboxane in Cuprophan-induced pulmonary hypertension. Kidney Int 1987;31:1072-9.
9. Pereira B, Dinarello C. Production of cytokines and cytokine inhibitor proteins in patients on dialysis. Nephrol Dial Transplant 1994;9:60-71.
10. 2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs. Circ Res 1990;66:596-607.
11. Van Epps DE, Chenoweth DE. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes. J Immunol 1984;132:2862-7.
12. Fernandez HN, Henson PM, Otani A, Hugh TE. Evaluation of C3a and C5a leukotaxis in vitro and in vivo conditions. J Immunol 1978;120:109-15.
13. Webster RO, Hong SR, Johnston RB, et al. Biological effects of human complement fragments C5a and C5a desArg on neutrophil function. Immunopharmacol 1980;2:201-19.
14. Henson PM, Zanolari B, Schwartman NA, Hong SR. Intracellular control of human neutrophil secretion: C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. J Immunol 1978;121:851-5.
15. Clancy RM, Dahinden CA, Hugli TE. Arachadonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-met-leu-phe or complement component CSa is independent of phospholipase activation. Proc Natl Acad Sci USA 1983;80:7200-4.
16. Werfel T, Sonntag G, Weber MH, Gotze O. Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase (CD13), tyrosine phoshatase (CD45), and Fcγ-RIII (CD16) upon stimulation with human C5a. J Immunol 1991;147:3909-14.
17. Schindler R, Gelfand JA, Dinarello CA. Recombinant C5a stimulates transcription rather than translation of interleukin-1 and tumor necrosis factor: translation signal provided by lipopolysaccharide or IL-1 itself. Blood 1990;76:1631-8.
18. Lundberg C, Marceau F, Hugli TE. C5a-induced hemodynamic and hematological changes in the rabbit: role of cyclooxygenase products and polymorphonuclear leukocytes. Am J Pathol 1987;128:471-83.
19. Swerlick RA, Yancy KB, Lawley TJ. A direct in vivo comparison of the inflammatory properties of human C5a and C5a desArg in human skin. J Immunol 1988;140:2376-81.
20. Burhop KE, Johnson RJ, Simpson J, et al. Biocompatibility of hemodialysis membranes: evaluation in an ovine model. J LAB CLIN MED 1993;121:276-93.
21. Hugli TE, Gerard C, Kawahara M, et al. Isolation of three separate anaphylatoxins from complement-activated human serum. Mol Cell Biochem 1981;414:59-66.
22. Johnson RJ, Chenoweth DE. Structure function of human C5a anaphylatoxin: selective modification of Tyr23 alters biological activity but not antigenicity. J Biol Chem 1985;260: 10339-45.
23. Johnson RJ, Tamerius JD, Chenoweth DE. Identification of an antigenic epitope and receptor binding domain of human C5a. J Immunol 1987;138:3856-62.
24. Fernandez HN, Hugli TE. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. J Biol Chem 1978;253:6955-64.
25. Baer A, Oroz M, Blanc B. Isolation and partial characterization of ovine lactoferrin. Experientia 1979;35:1554-5.
26. Van Epps DE, Simpson S, Johnson RJ. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a. J Immunol 1993; 150:246-52.
27. Baggolini M, Boulay F, Badwey JA, Curnutte JT. Activation of neutrophil leukocytes: chemoattractant receptors and respiratory burst. FASEB J 1993;7:1004-10.
28. Lewis SL, Van Epps DE, Chenoweth DE. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients. Blood Purif 1987;5:138-54.
29. Klempner MS, Gallin JI, Balow JE, Van Kammen DP. The effect of hemodialysis and C5a desArg on neutrophil subpopulations. Blood 1980;55;777-83.
30. Cohen MS, Elliot DM, Chaplinski T, Pike MM, Niedel JE. A defect in the oxidative metabolism of human polymorphonuclear leukocytes that remain in circulation early in hemodialysis. Blood 1982;60:1283-9.
31. Descamps-Latscha B, Goldfarb B, Nguyen AT, et al. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialysis patients: a randomized prospective study. Nephron 1991; 59:279-85.
32. Lewis SL, Van Epps DE. Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 1987;9: 381-95.
33. Himmelfarb J, Zaoui P, Hakim R. Modulation of granulocyte LAM-1 and MAC-1 during dialysis - a prospective, randomized controlled trial. Kidney Int 1992;41:388-95.
34. Tielemans CL, Delville J-PC, Husson CP, et al. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin Nephrol 1993;39:158-65.
35. Sengeløv H, Kjeldsin L, Borregaard N. Control of exocytosis in early neutrophil activation. J Immunol 1993;150:1535-43.
36. 2+ uptake in granule-free cytoplasts. Proc Natl Acad Sci USA 1984;81:1416-20.
37. Böhler J, Donaver J, Birmelin M, et al. Mediators of complement-independent granulocyte activation during hemodialysis: role of calcium, prostaglandins and leukotrienes. Nephol Dial Transplant 1993;8:1359-65.
38. 2-integrins are required for neutrophil degranulation induced by hemodialysis membranes. Kidney Int 1993;43:649-60.
39. Horl WH, Riegel W, Steinhauer HB, et al. Granulocyte activation during hemodialysis. Clin Nephrol 1986;26:S30-4.
40. Shastri KA, Logue GL, Stern MP, et al. Neutrophil lactoferrin release during open heart surgery is unrelated to complement activation. ASAIO J 1994;40:56-61.
41. Hugh TE, Marceau F. Effects of the C5a anaphylatoxin and its relationship to cyclooxygenase metabolites in rabbit vascular strips. Br J Pharmacol 1985;84:725-33.
42. Haviland DL, McCoy RL, Whitehead WT, et al. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 1995;154:1861-9.